![[Article Title]](https://media.americanpharmaceuticalreview.com/m/28/article/628507-134x100.jpg)
Rapid microbiology methods have moved from a forward-looking idea to an operational priority in pharma. In this interview, microbiology experts from Eagle Analytical explain what's driving adoption, where these methods add value across the quality workflow, how to choose the right technology, and how to make a strong regulatory and ROI case. Download the full interview to see where rapid microbiology is heading next.